Social Clips

Genzyme will be presenting an interactive digital experience at their conference booth this year and will share initial survey results from the experience through the @GenzymeCorp Twitter handle. Each time a visitor participates in their interactive booth and every time someone retweets using the hashtag #vsMS, the company will donate…

This is the second ECTRIMS conference held in Barcelona. The first one was held in 1992 and had 250 attendees. This year’s conference has already posted a new record of 8,832 participants! #ECTRIMS2015 For full coverage on social media for #ECTRIMS2015 go to http://bit.ly/ECTRIMS2015…

#msboston2014…

Follow #ectrims2015…

Next Next Next Next Next Next Next…

Next Next Next Next Next Next Next…

Next Next Next Next Next Next Next…

Here is what you need to read before #ECTRIMS2015 1.       Could Genentech’s Ocrelizumab Become the First Effective Primary Progressive MS Therapy?   2.      Ocrelizumab: a Promising New Treatment for Multiple Sclerosis with Minimal Side Effects   3.      Roche’s Ocrelizumab Found to be Superior to…

Tune in to MS News Today for full, on-site coverage of ECTRIMS 2015. Join us on twitter @MSNewsToday and keep track of these hashtags: #ECTRIMS2015 / #MSNewsToday  Facebook: http://on.fb.me/1FLwA11…

Check the MS Radio for songs dedicated to MS! Click here! Read more about the MS Radio!…

The JC virus can be the cause of Progressive Multifocal Leukoencephalopathy, a brain disease that affects more than 560 MS patients in the world. Find more about the possible new vaccine treatment revealed by two studies here: http://bit.ly/1O5QcxQ…

An already approved medication used for bladder problems might help to treat multiple sclerosis, according to researchers at the State University of New York at Buffalo. The research appeared in the Journal of Neuroscience and was funded by the National Multiple Sclerosis Society, the Kalec Multiple Sclerosis…

Read the complete article here: http://bit.ly/1RfUhzp  …